Here are five highlights:
1. The OsteoCool System is the only cooled radiofrequency ablation technology that offers simultaneous, dual-probe capabilities, providing procedural flexibility and predictable, customized treatment.
2. Cooled RF ablation uses targeted high-frequency energy to destroy cancer cells.
3. This device can be used on patients with painful spine metastases.
4. Metastatic bone disease has been reported to occur in 60 percent to 80 percent of cancer patients, most frequently among patients with primary malignancies of the breast, prostate, liver and lung.
5. Seventy percent of metastatic bone cancer patients develop at least one lesion in the spine.
More articles on devices and implants:
21 spine devices receive FDA 510(k) clearance in December
Intellijoint Surgical wins Frost & Sullivan award for enabling technology leadership: 3 things to know
Forbes names Vertera Spine Founder Allen Chang to ’30 under 30′ list: 4 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
